A randomized, multicentre, open‐label, parallel‐group trial to compare the efficacy and safety profile of daming capsule in patients with hypercholesterolemia
- 14 January 2009
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 23 (7), 1039-1042
- https://doi.org/10.1002/ptr.2654
Abstract
To study the efficacy and tolerability of Daming capsule (DMC) in Chinese patients with hyperlipidemia, a randomized, multi‐centre, open‐label, parallel‐group trial was conducted. Sixty enrolled patients with hyperlipidemia allocated to six medical centers were randomly divided into two groups of 30 individuals each. One group received DMC 2 g b.i.d. for 6 weeks, and the other received pravastatin 10 mg o.d. for 6 weeks. For efficacy assessment, serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL‐C) and high density lipoprotein cholesterol (HDL‐C) were measured before and after drug treatment. Serum TC and LDL‐C levels in the DMC‐treatment group were significantly decreased compared with those before treatment (p < 0.05), while TG and HDL‐C levels did not change much. Tolerability was assessed by heart rate (HR), blood pressure (BP), body mass index (BMI), alanine aminotransferase (ALT) and creatinine (Cr), which were not changed in either the DMC or pravastatin groups at 3 and 6 weeks (p > 0.05). Besides, eight patients experienced diarrhea during DMC treatment and two experienced myalgia and epigastric discomfort during pravastatin treatment. Based on the above results, it was concluded that DMC may be a good candidate for the treatment of hyperlipidemia and further clinical trials are warranted. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 9 references indexed in Scilit:
- Lipid Abnormalities in WomenCardiology in Review, 2006
- Analysis of Cardioprotective Effects Using Purified Salvia miltiorrhiza Extract on Isolated Rat HeartsJournal of Pharmacological Sciences, 2006
- Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical UseThe Journal of Clinical Pharmacology, 2005
- Relationship between obesity and cardiovascular risk factors: findings from a multi-state screening project in the United StatesCurrent Medical Research and Opinion, 2005
- Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarctionLife Sciences, 2005
- A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transitEuropean Journal of Pharmacology, 2005
- The effect of gemfibrozil on the pharmacokinetics of rosuvastatinClinical Pharmacology & Therapeutics, 2004
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002